Amid sudden global spike in COVID cases, Union health minister Mansukh Mandaviya on Thursday reviewed the status, adequacy of COVID management drugs and production capacities with representatives of pharma companies through a VC, here today.
The virtual meeting was held to effectively handle any situation arises in view of the spike in COVID19 cases in some countries worldwide.
Through a presentation, the Union Minister was briefed regarding the evolving global scenario. “India’s pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the pandemic, but also be in a position to supply medicines to 150 countries”, Mandaviya said.
He stressed that it has been achieved without any fall in quality and no hike in the price of the medicines. The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor production and availability of APIs as well as formulations of essential medicines for COVID management.
The health minister asked the Pharma company to ensure adequate stocks and availability of all drugs including COVID drugs in the supply chain up to the retail level. The pharma companies hailed the timely review meeting and assured their continued support.
The Pharma company assured to manage the supply chain of COVID drugs.
Patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts…
As the air pollution levels spike and reached alarming levels in many cities across the…
Highlighting that Antimicrobial Resistance is a global health threat, the Minister of State for health…
SFI Green Heartfulness Run was held on November 17, 2024 at Indirapuram starting from Habitat…
The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…
Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…